RadNet will acquire Gleamer for up to $270 million, aiming to make DeepHealth the largest global provider of radiology clinical AI solutions.
Key Details
- 1RadNet acquires Paris-based AI firm Gleamer for up to $270 million.
- 2Gleamer serves over 700 customers across 44 countries, with FDA-cleared solutions for musculoskeletal, breast, lung, and brain imaging.
- 3The combined entity aims to become the largest provider of radiology clinical AI solutions globally.
- 4Gleamer's portfolio spans X-ray, mammography, CT, and MRI, and its products have analyzed over 30 million exams at more than 2,250 locations.
- 5Gleamer is expected to reach $30 million in annual recurring revenue in 2024, with compound annual growth over 90% from 2022–2025.
Why It Matters
This acquisition positions RadNet and its DeepHealth subsidiary as a leader in AI-driven radiology, further driving consolidation and innovation in imaging AI. The move underscores the growing demand for robust, FDA-cleared AI solutions across multiple imaging modalities.
Source
Radiology Business
Related News
•Radiology Business
Framework Assesses Real-World Financial Impact of Radiology AI Adoption
A new analysis presents a financial calculator for objectively assessing the return on investment (ROI) of implementing radiology AI solutions.
•Radiology Business
AI Technique Unveils Previously Hidden MS Gray Matter Lesions on MRI
Researchers developed an AI-enhanced method to detect previously invisible gray matter lesions in multiple sclerosis using MRI.
•Radiology Business
Generative AI Set to Transform Chest X-ray Reporting and Quality
Generative AI models can now produce full radiology reports from chest X-rays, promising increased diagnostic accuracy and efficiency.